Skip to content

Our publications

Since its inception, Inovarion has contributed to the completion of high-level research projects. Our scientists have actively participated to studies resulting in publications in prestigious, high-impact journals. These publications span a wide range of fields within biology, driving innovation and fostering progress across numerous therapeutic and scientific domains.

See all on Pubmed
Filter :
Med Sci (Paris)
Immunology

Basophil granulocytes control pathogenic accumulation of T follicular helper cells during lupus

Learn more
Haematologica
Immunology

A fully humanized von Willebrand disease type 1 mouse model as unique platform to investigate novel therapeutic options

Learn more
Commun Biol
Immunology

Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways

Learn more
Sci Rep
Immunology

Seasonal and climatic influence on respiratory infections in children with cystic fibrosis

Learn more
Eur Respir J
Immunology

Genome-wide association study of susceptibility to Pseudomonas aeruginosa infection in cystic fibrosis

Learn more
Nature communications
Immunology

PD-L1- and IL-4-expressing basophils promote pathogenic accumulation of T follicular helper cells in lupus

Learn more
Frontiers in Immunology
Immunology

Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia

Learn more
iScience
Immunology

Activating FcγR function depends on endosomal-signaling platforms

Learn more
Current Opinion in Immunology
Immunology

M1-aminopeptidase family – beyond antigen-trimming activities

Learn more
Blood.
Immunology

A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD

Learn more
Immunity
Immunology

Human anti-smallpox long-lived memory B cells are defined by dynamic interactions in the splenic niche and long-lasting germinal center imprinting

Learn more
Cancers (Basel)
Immunology

Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3 +, CD8 +, and Immunoscore Are Associated with a Pathological Complete Response

Learn more